News

Denmark removes one-shot J&J vaccine over blood clot fears

Denmark removes one-shot J&J vaccine over blood clot fears
Health
COPENHAGEN -- Denmark removed the single-dose Johnson & Johnson COVID-19 shot from its vaccination program to investigate reports of rare but potentially dangerous blood clots, health authorities said Monday.

Denmark has already taken the AstraZeneca shot out of its vaccination program for the same reason. Both the J&J and AstraZeneca shots are made with similar technology.

The that it "has concluded that the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect."

It added that the European Medicines Agency has concluded that "there is a possible link between rare but severe cases of blood clots (VITT) and the COVID-19 vaccine from Johnson & Johnson."

"As the COVID-19 epidemic in Denmark is currently under control, and the vaccination rollout is progressing satisfactorily with other available vaccines, the Danish Health Authority has decided to continue the national vaccination campaign without the COVID-19 vaccine from Johnson & Johnson."

Helene Probst, deputy director general at the Danish Health Authority, noted Monday s decision means that Denmark s vaccination calendar will be pushed back up to four weeks.

The decision was made at a meeting Monday in parliament between Health Minister Magnus Heunicke and lawmakers from the different parties.

The vaccines made by Pfizer-BioNTech and Moderna represent the bulk of the jabs given in the Scandinavian country of nearly 6 million people. More more than 1.2 million residents have either received the first or the two shots, according to official figures.
Read more on CTVnews
News Topics :
Similar Articles :
World
COPENHAGEN Denmark removed the single dose Johnson & Johnson COVID 19 shot from its vaccination program to investigate reports of rare but potentially dangerous blood clots, health authorities said Monday. Denmark...
World
Slovakia s Prime Minister Eduard Heger receives his first AstraZeneca COVID 19 vaccination at the National Soccer Stadium in Bratislava, Slovakia, Saturday, May 1, 2021. The AstraZeneca coronavirus vaccine should remain...
Top Stories
LONDON Experts at the agency that regulates drugs for the European Union said Tuesday that a warning about very unusual blood clots should be added to labels...
Top Stories
A U.S. health panel says it s time to resume use of Johnson & Johnson s COVID 19 vaccine, despite a very rare risk of blood clots. Out of nearly 8...
Health
LONDON Experts at the European Medicines Agency are preparing to present Tuesday the conclusions of their investigation into possible links between the Johnson & Johnson coronavirus vaccine...